The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease

被引:66
作者
Glodzik-Sobanska, Lidia
Pirraglia, Elizabeth
Brys, Miroslaw
de Santi, Susan
Mosconi, Lisa
Rich, Kenneth E.
Switalski, Remigiusz
Saint Louis, Leslie
Sadowski, Martin J.
Martiniuk, Frank
Mehta, Pankaj [2 ]
Pratico, Domenico [3 ]
Zinkowski, Raymond P. [4 ]
Blennow, Kaj
de Leon, Mony J. [1 ,5 ]
机构
[1] NYU, Sch Med, Dept Psychol, Ctr Brain Hlth, New York, NY 10016 USA
[2] New York State Off Mental Retardat & Dev Disabil, Inst Basic Res, Staten Isl, NY USA
[3] Univ Penn, Philadelphia, PA 19104 USA
[4] Appl NeuroSolut, Vernon Hills, IL USA
[5] Nathan Kline Inst Orangeburg, Orangeburg, NY USA
关键词
Biomarkers; Cerebrospinal fluid; Alzheimer's disease; Normal aging; CEREBROSPINAL-FLUID TAU; APOLIPOPROTEIN-E GENOTYPE; MILD COGNITIVE IMPAIRMENT; AMYLOID-BETA-PEPTIDE; PHOSPHORYLATED TAU; DIFFERENTIAL-DIAGNOSIS; BIOCHEMICAL MARKER; LIPID-PEROXIDATION; OXIDATIVE STRESS; EPSILON;
D O I
10.1016/j.neurobiolaging.2007.08.019
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
While cerebrospinal fluid (CSF) biomarkers are of use in the prediction and diagnosis of Alzheimer's disease our understanding of the background effects of age and the ApoE genotype is limited. Seventy-eight community-based normal volunteers (mean age 60 +/- 10 years, range 36-86) were examined to determine the relationships between CSF measures of total tau (T-tau), hyperphosphorylated tau (P-tau 231), amyloid beta (A beta 42/A beta 40 ratio), and isoprostane (IP) with age and ApoE genotype. The results showed that age by epsilon 4 genotype interactions were found for P-tau231 (beta = 1.82; p < 0.05) and IP (beta = 1.6; p < 0.05). T-tau CSF concentration increased with age. The increasing CSF concentrations of P-tau and IP in epsilon 4 carriers suggest that early tauopathy and oxidative stress may be related to the increased risk for AD. The data also suggest that T-tau changes are more age dependent than A beta changes. The evidence that P-tau231 and IP are the earliest markers for the neuronal damage related to AD awaits longitudinal study. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:672 / 681
页数:10
相关论文
共 67 条
[1]   Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease:: a community based follow up study [J].
Andreasen, N ;
Vanmechelen, E ;
Van de Voorde, A ;
Davidsson, P ;
Hesse, C ;
Tarvonen, S ;
Räihä, I ;
Sourander, L ;
Winblad, B ;
Blennow, K .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (03) :298-305
[2]   Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology [J].
Arai, H ;
Morikawa, Y ;
Higuchi, M ;
Matsui, T ;
Clark, CM ;
Miura, M ;
Machida, N ;
Lee, VMY ;
Trojanowski, JQ ;
Sasaki, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (02) :262-264
[3]   Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease [J].
Augustinack, JC ;
Schneider, A ;
Mandelkow, EM ;
Hyman, BT .
ACTA NEUROPATHOLOGICA, 2002, 103 (01) :26-35
[4]   INCIDENCE OF DEMENTIA AND PROBABLE ALZHEIMERS-DISEASE IN A GENERAL-POPULATION - THE FRAMINGHAM-STUDY [J].
BACHMAN, DL ;
WOLF, PA ;
LINN, RT ;
KNOEFEL, JE ;
COBB, JL ;
BELANGER, AJ ;
WHITE, LR ;
DAGOSTINO, RB .
NEUROLOGY, 1993, 43 (03) :515-519
[5]   Neuropathology of older persons without cognitive impairment from two community-based studies [J].
Bennett, D. A. ;
Schneider, J. A. ;
Arvanitakis, Z. ;
Kelly, J. F. ;
Aggarwal, N. T. ;
Shah, R. C. ;
Wilson, R. S. .
NEUROLOGY, 2006, 66 (12) :1837-1844
[6]   CSF markers for pathogenic processes in Alzheimer's disease: diagnostic implications and use in clinical neurochemistry [J].
Blennow, K ;
Vanmechelen, E .
BRAIN RESEARCH BULLETIN, 2003, 61 (03) :235-242
[7]   CSF biomarkers for mild cognitive impairment [J].
Blennow, K .
JOURNAL OF INTERNAL MEDICINE, 2004, 256 (03) :224-234
[8]   Alzheimer's disease [J].
Scheltens, Philip ;
De Strooper, Bart ;
Kivipelto, Miia ;
Holstege, Henne ;
Chetelat, Gael ;
Teunissen, Charlotte E. ;
Cummings, Jeffrey ;
van der Flier, Wiesje M. .
LANCET, 2021, 397 (10284) :1577-1590
[9]   Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up [J].
Blomberg, M ;
Jensen, M ;
Basun, H ;
Lannfelt, L ;
Wahlund, LO .
NEUROSCIENCE LETTERS, 1996, 214 (2-3) :163-166
[10]   Cerebrospinal fluid tau levels increase with age in healthy individuals [J].
Blomberg, M ;
Jensen, M ;
Basun, H ;
Lannfelt, L ;
Wahlund, LO .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2001, 12 (02) :127-132